See all

Souzan Sanati, MD

Assistant Professor, Pathology & Immunology

Phone314-747-5648

Fax314-747-2663

Emailssanati@wustl.edu

Education

  • Medical Degree: Iran University of Medical Services
  • Residency: University of Texas Medical Branch, Galveston, TX (2005)
  • Surgical Pathology Fellowship: Washington University, St. Louis, MO (2006)
  • Cytopathology Fellowship: Washington University, St. Louis, MO (2007)
  • Breast & Gynecologic Pathology Fellowship: Yale University, New Haven, CT (2009)

Board Certifications

  • Anatomic & Clinical Pathology Board Certified
  • Cytopathology Board Certified

Clinical Interests

  • Breast Pathology
  • Cytopathology
  • General Surgical Pathology

Research Interests

My research focus is in the area of breast pathology particularly identification of new prognostic biomarkers and therapeutic targets. I am involved in many clinical trials and translational research related to breast cancer.

Service to the University

2013 – Present  Medical School Admissions Committee

Publications

pub med search

Khoury T, Kumar PR, Li Z, Karabakhtsian RG, Sanati S, Chen X, Wang D, Liu S, Reig B. Lobular Neoplasia Detected in MRI-Guided Core Biopsy Carries a High Risk for Upgrade: A Study of 63 Cases from Four Different Institutions. Mod Pathol. 2016;29(1):25-33. PMID: 26564004
Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE. Axillary ultrasound accurately excludes clinically significant lymph node disease with early stage breast cancer. Ann Surg. 2016. PMID:26779976
Khwaja SS, Ivanovich J, DeWees TA, Ochoa L, Mullen DF, Thomas M, Margenthaler JA, Cyr A, Naughton M, Sanati S, Eberlein TJ, Gillanders WE, Aft RL, Zoberi JE, Zoberi I. Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer. Cancer Med. 2015. PMID: 26687192
Khoury T, Li Z, Sanati S, Karabakhtsian R, Kumar P, Reig B. The Risk of Upgrade for Atypical Ductal Hyperplasia Detected on MRI-Guided Biopsy: A Study of 100 Cases from Four Academic Institutions. Histopathology. August 2015. PMID: 26291517
Gatalica Z, Vranic S, Ghazalpour A, Xiu J, Tolgay Ocal I, McGill J, Bender RP, Disciano E, Schlum A, Sanati S, Palazzo J, Reddy S, Pockaj B. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. Oncotarget. 2015 Nov. [Epub ahead of print] PMID: 26625196
Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S. Improved Health Care Resource Utilization and Patient Care with the Use of Rapid On-Site Evaluation for Endobronchial Ultrasound Fine Needle Aspiration Biopsy.. Cancer Cytopathol. 2013;121(10):544-51., 2013 Abstract
Sanati S, Allred DC.. “The progression of pre-invasive to invasive cancer.” In: Pre-invasive Disease: Pathogenesis and Clinical Management. Rebecca Fitzgerald. Springer Science and Business Media. 2011.
Sanati S, Huettner PC, Ylagan L.. PROEX C immunostain in the evaluation of squamous and glandular lesions in the cervical specimens.. Int J Gynecol Pathol. 2010 Jan;29(1):79-87, 2010Abstract
Sanati S, Watson MA, Salavagionne AL, Humphrey PA.. Gene expression profiles of ductal versus acinar adenocarcinomas of the prostate.. Mod Pathol. 2009;22(10):1273-1279, 2009 Abstract


Assistant
Kim Green
314-747-8159
greenk@path.wustl.edu

Office Location: BJC-IH Building, Room 3414